General Information of Drug (ID: DMU5761)

Drug Name
PF-06282999
Indication
Disease Entry ICD 11 Status REF
Acute coronary syndrome BA41 Phase 1 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C13H12ClN3O3S
Canonical SMILES
COC1=C(C=C(C=C1)Cl)C2=CC(=O)NC(=S)N2CC(=O)N
InChI
1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21)
InChIKey
ICYNYWFGIDGBRD-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
71571306
CAS Number
1435467-37-0
TTD ID
D09DXX
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT01626976) A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects. U.S. National Institutes of Health.